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Methylation profiling in individuals with uniparental
disomy identifies novel differentially methylated
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The maternal and paternal genomes possess distinct epigenetic marks that distinguish them at imprinted loci. In order to
identify imprinted loci, we used a novel method, taking advantage of the fact that uniparental disomy (UPD) provides
a system that allows the two parental chromosomes to be studied independently. We profiled the paternal and maternal
methylation on chromosome 15 using immunoprecipitation of methylated DNA and hybridization to tiling oligonucle-
otide arrays. Comparison of six individuals with maternal versus paternal UPD15 revealed 12 differentially methylated
regions (DMRs). Putative DMRs were validated by bisulfite sequencing, confirming the presence of parent-of-origin-
specific methylation marks. We detected DMRs associated with known imprinted genes within the Prader-Willi/Angelman
syndrome region, such as SNRPN and MAGEL2, validating this as a method of detecting imprinted loci. Of the 12 DMRs
identified, eight were novel, some of which are associated with genes not previously thought to be imprinted. These include
a site within intron 2 of IGF1R at 15q26.3, a gene that plays a fundamental role in growth, and an intergenic site upstream of
GABRG3 that lies within a previously defined candidate region conferring an increased maternal risk of psychosis. These
data provide a map of parent-of-origin-specific epigenetic modifications on chromosome 15, identifying DNA elements
that may play a functional role in the imprinting process. Application of this methodology to other chromosomes for
which UPD has been reported will allow the systematic identification of imprinted sites throughout the genome.
[Supplemental material is available online at http://www.genome.org. The microarray data from this study have been
submitted to the NCBI Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo) under accession no. GSE22188.]
Imprinting is a phenomenon in which the expression status of a
gene is dependent on the sex of the parent from which it is in-
herited. Imprinted genes generally exhibit monoallelic expression
accompanied by parent-of-origin-specific epigenetic marks such as
differential DNA methylation and histone modifications that dis-
tinguish thematernal and paternal genomes at these loci (Reik and
Walter 2001; Dindot et al. 2009). More than 60 imprinted genes
have been identified in humans (http://www.geneimprint.com/),
and their clustered nature suggests that many are regulated by re-
gional control mechanisms.
To date, the discovery of imprinted sites in both mouse and
human has largely been driven through the use of phenotype-
based approaches. The vast majority of loci subject to parent-of-
origin effects were first recognized through the observation that
maternal and paternal transmission of the same genetic mutation
results in different phenotypes (Nicholls et al. 1989). For example,
the identification of imprinted gene clusters in 15q11-q13 associ-
ated with Prader-Willi/Angelman syndrome, 11p11.5 associated
with Beckwith-Wiedemann syndrome, and imprinted loci at
14q32, 6q24, and 20q13.2 were all catalyzed by the initial obser-
vation that genetic disease occurred specifically in patients with
either uniparental disomy (UPD) or deletions of these regions of
specific parental origin. In combination with chromosomal engi-
neering techniques that can systematically generate defined aneu-
ploidies, this notion has been applied to screen the mouse genome
for imprinting with great success, resulting in the identification of
more than 130 murine imprinted genes (Williamson et al. 2009).
However, because this methodology relies on the recognition of
overt phenotypic differences between individuals to detect im-
printing, it is likely to miss imprinting that may cause subtle phe-
notype differences or those thatmanifest in ways that are not easily
recognized by typical methods of phenotypic characterization.
Further, imprinted genes will also be missed or masked by pheno-
types that are lethal.
In order to circumvent this limitation, a variety of genomic
techniques have been developed to identify parent-of-origin
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effects. Several previous studies have attempted to detect im-
printing based on the differential expression of parental alleles at
imprinted loci. Studies using subtractive cDNA hybridization
(Kaneko-Ishino et al. 1995) and high-throughput cDNA sequencing
in hybrid mouse strains (Wang et al. 2008) have been used to detect
imprinted expressionwith some success. However, these approaches
are limited in that they can only assay the subset of genes expressed
in the tissue(s) under investigation, and for some genes, imprinted
expression is only observed in specific tissues or at certain de-
velopmental stages (Deltour et al. 1995; Rougeulle et al. 1997; Zhou
et al. 2006). Furthermore, sequencing-based approaches are only
able to assay allelic bias in genes containing transcribed poly-
morphisms (Daelemans et al. 2010).
Alternative approaches to detect imprinting have used the
fact that the maternal and paternal genomes have differential
epigenetic marks at most imprinted loci. This approach has the
advantage over expression-based methods, in that these differen-
tialmethylationmarks are generally conserved, even in tissues that
lack imprinted expression (Dockery et al. 2009). The presence of
overlapping euchromatin and heterochromatin marks has been
used to highlight imprinted domains in human (Wen et al. 2008),
and restriction landmark genome scanning (Hayashizaki et al.
1994) and methylation-sensitive representational difference analy-
sis (Kelsey et al. 1999; Smith et al. 2003) have been applied as
methods to detect differentially methylated regions in the mouse
genome. However, the reliance of these latter techniques on re-
striction enzyme digestion means that they can only assay a small
subset of CpGs that overlap the enzyme recognition site, and if used
in outbred genomes, are liable to artifacts generated by the presence
of single nucleotide variants that alter restriction patterns.
Because one of the key features of imprinted genes is the pres-
ence of parent-of-origin-specific methylation, we hypothesized that
the systematic comparisonofDNAmethylationpatterns inmaternal
versus paternal chromosomes should represent an optimal method
for the detection of imprinted loci. Based on this hypothesis, we
have taken advantage of the fact that uniparental disomy provides
a unique system that allows the separate study of chromosomes
derived from a single parent and combined this with amethodology
in which the methylation of entire chromosomes can be analyzed
in an unbiased fashion. By analyzing methylation patterns in cases
of maternal UPD15 (matUPD15) and paternal UPD15 (patUPD15)
using immunoprecipitation of methylated DNA and high-density
tiling arrays with complete coverage of human chromosome 15,
we generated separate methylation profiles of the maternally and
paternally derived alleles. Comparison of the two parental epi-
genotypes identifies numerous loci on chromosome 15 that show
parent-of-origin-specific methylation differences, defining a set of
DNA elements that are likely responsible for the establishment and/
or maintenance of imprinting on this chromosome. We identify
novel imprinted loci both within and outside of the known PWS/AS
imprinted domain, suggesting candidate loci that may exert parent-
of-origin effects in several human phenotypes.
Results
Systematic comparison of methylation profiles generated from
three patients with matUPD15 and three patients with patUPD15
resulted in the identification of a total of 80 5-probe windows,
which exceeded our statistical threshold. Prior to further analysis,
a 1-kb region was then defined centered on the most significant
(central) probe in each DMR. Many of these putative DMRs were
composed of multiple overlapping 1-kb windows, which were
collapsed into 48 nonredundant loci (Supplementary Table 1). As
(1) underlying copy-number variations (CNVs) can sometimes
cause false signals in ChIP data thatmimic enrichment peaks (Vega
et al. 2009; A Sharp, unpubl.), (2) nonunique sequences are highly
enriched for CNVs and yield lower quality microarrays data due
to cross-hybridization artifacts (Sharp et al. 2005, 2007), and (3)
imprinted sites were not expected to occur in nonunique or CNV
regions, all sites that overlapped either a high-resolution set of
CNVs (Conrad et al. 2010) or segmental duplications (http://
www.genome.ucsc.edu/) were removed (n = 7). Prior to incor-
porating this filtering step, we tested several of these putative
DMRs that overlapped known CNVs using bisulfite sequencing, but
failed to detect any significant methylation differences between
matUPD15 and patUPD15 cases at these loci. On re-examination of
the array data, we observed many regions of significant difference
that overlapped CNVs and that failed to validate by bisulfite se-
quencing showed a characteristic pattern that differed from that
observed at genuine DMRs (Supplementary Fig. 3). A further filter
was applied to the remaining 41 regions to remove those that had
a low CpG density (<1 CpG/200 bp, n = 10), as this was considered
below the sensitivity of meDIP. This resulted in a filtered set of 31
putative DMRs that showed consistent significant differences be-
tween individualswithmatUPD15 andpatUPD15. Twopairs of these
loci were separated by <1 kb and were merged into single regions,
resulting in a final set of 29 putative DMRs (Supplementary Table 2).
Many of these sites were associated with known imprinted
genes within the 15q11-q13 region that is commonly deleted in
the Prader-Willi/Angelman syndrome, and some had been iden-
tified as DMRs in previous studies (Dittrich et al. 1992; Sutcliffe
et al. 1994; Buiting et al. 1995; Supplementary Table 2). These in-
cludedmultiple DMRs upstream of or overlapping the SNRPN gene
(Supplementary Fig. 4) and others located at the promoter region
of MAGEL2, thus showing the ability of our method to detect
known imprinted loci. However, many other potential novel
DMRs on chromosome 15 were also identified.
In order to validate putative DMRs identified by array analy-
sis, we used bisulfite modification, followed by PCR and se-
quencing of the candidate loci. Bisulfite sequencing assays were
designed for 22 of the 29 putative DMRs and were used to assess
methylation at these sites inmultiple patientswithmatUPD15 and
patUPD15 and in biparental controls. For 12 loci, bisulfite se-
quencing confirmed the presence of high levels of methylation in
matUPD15 cases, low or absent methylation in patUPD15 cases,
and showed intermediate methylation in biparental controls,
consistentwith the array data indicatingmono-allelicmethylation
of thematernal allele at these loci (Fig. 1; Table 1). These validation
studies were performed using both the original six UPD samples
used for the microarray screen, in addition to four other UPD cases
that had not been tested by array. For each locus, the results of
bisulfite sequencing were concordant across all cases of UPD, and
in these UPD cases we saw no evidence of polymorphism at any of
the loci sequenced. The remaining 10 candidate sites tested were
found not to show any methylation difference between maternal
and paternal chromosomes, and thus, represent false positives
from the microarray resulting from the use of a low-stringency
statistical threshold in our DMR analysis.
For twoDMRs, we further confirmed the presence ofmaternal-
specific methylation (chr15:25,598,371–25,599,471 and chr15:
97,226,553–97,227,868) by cloning and sequencing individual
alleles amplified from a HapMap control individual heterozygous
for a single nucleotide polymorphism (SNP)within each amplicon.
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showed significantly higher levels of methylation on the mater-
nally derived chromosome (Fig. 1).
Bisulfite sequencing of the DMR distal to GABRG3 (chr15:
25,598,371–25,599,471) revealed apparent polymorphic imprint-
ing at this site.While themajority of cases examined showed results
consistent with mono-allelic methylation, three of 26 individuals
with normal biparental inheritance of chr15 showed complete ab-
sence of methylation, suggesting that this site shows loss of im-
printing in a minority of individuals.
Allele-specific expression studies of IGF1R using RNA extracted
from peripheral blood and placenta of a normal control, and of
OCA2 using a cultured melanocyte line, did not show any allelic
bias in their expression in the samples analyzed.
We investigated two genomic features that have been sug-
gested to be associated with imprinted loci: (1) periodicity of CpG
dinucleotides (Jia et al. 2007), and (2) DNA secondary structure
(Dindot et al. 2009). Periodicity analysis within the 12 confirmed
DMRs showed no consistent pattern with the distribution of CpG
dinucleotides, either within any individual region or in a com-
posite dataset (Supplementary Figs. 5, 6). Analysis of predicted sites
of guanine-quadruplex DNA within 15q11-q13 showed that the
strongest predicted region of G-quadruplex within the entire 6-Mb
Figure 1. Identification of differentially methylated regions within intron 2 of the IGF1R gene in 15q26.3 and distal toGABRG3 in 15q12. (A,D) Images
show the smoothedmean log2 ratios from three individuals with paternal UPD15, three individuals withmaternal UPD15, the difference between these
two profiles, and putative DMRs identified by statistical analysis uploaded as custom tracks in the UCSC Genome Browser. The DMR within intron 2
of the IGF1R gene contains the sequence RACCACGTGGTY, corresponding to the methylation-sensitive consensus binding motif for MYC/MAX
(Solomon et al. 1993), and in vivo binding of both MYC and MAX to this site in K562 cells is confirmed by chromatin immunoprecipitation
with massively parallel sequencing (ChIP-seq). Each plot shows a 50-kb window centered on each DMR: (A) chr15:97,203,000–97,253,000;
(D) chr15:25,575,000–25,625,000. Also shown are the genomic coordinates (hg18), cytogenetic band, CpG dinucleotides, and CpG islands defined
using epigenetic criteria (Bock et al. 2007). (B,E ) Sequencing after bisulfite modification of the DNA, which converts unmethylated cytosine residues
to uracil, confirms that these two loci both show differential methylation between matUPD15 and patUPD15 samples. A biparental control shows
the expected pattern with an approximately equivalent mix of both methylated and unmethylated alleles. (C,F ) Individual bisulfite-treated alleles
fromHapMap individual NA12753 were isolated by cloning and divided by parental origin using heterozygous informative SNPs within each amplicon.
In each case, the maternally derived allele is predominantly methylated, while the paternally derived allele is predominantly unmethylated, in
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region coincides with a DMR overlapping a CpG island within
intron 1 of the SNRPN gene (chr15:22,643,652–22,645,255, Sup-
plementary Fig. 7). The predicted G-quadruplex structure maps to
a (CGGGGG)n tandem repeat that lies within the putative AS im-
printing centre (Buiting et al. 1995).
Discussion
Methylation profiling in uniparental tissues allows the systematic
identification of imprinted loci, and we describe 12 regions on
chromosome 15 that show differential methylation between pa-
ternal and maternal alleles (Table 1). Of note, we identify a novel
DMR within intron 2 of the IGF1R gene at 15q26.3, a region not
previously thought to be imprinted (Fig. 1). The 11 other con-
firmed regions of differential methylation all occurred within
15q11-q13, a region that is known to contain multiple imprinted
transcripts implicated in the phenotypes of Prader-Willi and
Angelman syndromes. Six DMRs occur overlapping or upstream of
SNRPN, two in the promoter region of MAGEL2, while three are
located intergenically more than 150 kb from the nearest anno-
tated gene (Fig. 2). We hypothesize that some or all of these DMRs
represent DNA elements that play a role in establishing or main-
taining the imprinted expression patterns of genes in this region.
As such, we suggest that they represent excellent candidate sites for
crypticmutation in cases of PWS/ASwithno knowngenetic defect.
In each case, differentially methylated regions were relatively
GC-rich regions, extending over hundreds of base pairs and in-
cluding multiple CpG residues. Strikingly, all 12 confirmed DMRs
were methylated on thematernal chromosome and unmethylated
on the paternal chromosome, consistent with the known excess
of maternally methylated imprinted regions identified to date
(Kobayashi et al. 2006). While many occur outside of CpG islands
defined by classical criteria, aside from a small number specifically at
the promoters of imprinted genes, all overlap a more recent map of
CpG islands identified using epigenetic data (Bock et al. 2007).
These observations indicate that these more sophisticated defini-
tions of CpG islands are much better predictors of genomic loci
subject to epigenetic modification compared with those defined
solely by sequence characteristics using arbitrary criteria (Gardiner-
Garden and Frommer 1987).
Two DMRs were identified ;180 kb upstream of NDN in
15q11.2, which overlap sites of RNA polymerase II and CTCF
binding that are enriched for histone H3K4 mono-, di-, and tri-
methylation. This epigenetic signature suggests that these may
represent either sites of unidentified imprinted transcripts or al-
ternatively regulatory or insulator elements for genes in cis (Sup-
plementary Fig. 8).
Our detection of a DMRwithin IGF1R (insulin-like growth fac-
tor 1 receptor) is arguably not surprising as the related genes IGF2
and IGF2R are both known to be imprinted in human and/or
mouse (Barlow et al. 1991; Giannoukakis et al. 1993). Monoallelic
maternal expression of IGF1R was observed in one case of Beck-
with-Wiedemann syndrome, but previous studies of IGF1R in
several normal human tissues have failed to detect any consistent
allelic expression bias (Howard et al. 1993; Ogawa et al. 1993), and
our analyses in blood and placenta also revealed no apparent bias
in IGF1R expression. However, these results do not exclude that
IGF1R shows imprinted expression that is limited to specific tis-
sues or developmental time points, phenomena that are observed
for many imprinted genes (Deltour et al. 1995; Rougeulle et al.
1997). For some genes, imprinting can manifest in subtle ways
such as alternative splicing and polyadenylation events (Kosaki
et al. 2000; Wood et al. 2008), or as seems likely in the case of
IGF1R, differential transcription-factor binding (Kim et al. 2003).
The IGF1RDMR contains the 12-bpMYC/MAXconsensus-binding
motif RACCACGTGGTY (Solomon et al. 1993), and immunopre-
cipitation experiments confirm that this region is bound by both
MYC and MAX in vivo (Fig. 1). As previous studies in mouse have
shown that binding of Myc/Max is dependent on the methylation
state of its binding site (Prendergast et al. 1991), the paternal and
Table 1. Twelve differentially methylated regions detected on
chromosome 15
Coordinates, hg18 Location
chr15:21,443,975–21,445,255 CpG island at promoter of MAGEL2
chr15:21,447,655–21,448,655 Promoter of MAGEL2
chr15:21,665,164–21,666,661 CpG island 181 kb distal to NDN
chr15:21,674,266–21,675,266 CpG island 189 kb distal to NDN
chr15:22,568,270–22,570,162 CpG island proximal to SNRPN
chr15:22,619,069–22,621,154 Promoter of SNRPN transcript
variants 3/4/5
chr15:22,643,652–22,645,255 CpG island in SNRPN intron 1
chr15:22,652,665–22,653,665 Promoter of SNRPN transcript
variant 2
chr15:22,673,962–22,675,359 CpG island in SNRPN intron 1
chr15:22,750,354–22,753,774 CpG island at promoter of
SNURF/SNRPN
transcript variant 1
chr15:25,598,371–25,599,471 CpG island 146 kb distal to GABRG3
chr15:97,226,553–97,227,868 CpG island in IGF1R intron 2
Figure 2. Differentially methylated regions in 15q11-q13 identified by comparative methylation profiling in patients with UPD15. Eleven of the 12
DMRs we identified lie within a 5-Mb region of proximal chromosome 15q (black bars). This includes multiple DMRs at the known imprinted genes
SNRPN and MAGEL2 in addition to several novel intergenic DMRs. The DMR distal to GABRG3 lies within a 687-kb region of 15q12-q13.1
(chr15:25,059,076–25,747,771) previously defined as likely to contain an imprinted locus which, when excess maternal copies are present, confers an
increased risk of psychosis in PWS patients (Webb et al. 2008). Genes are colored according to their expression status, as reported by previous studies. A
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maternal copies of IGF1R are likely differentially regulated by
MYC/MAX binding as a result of maternal-specific methylation.
IGF1R plays a fundamental role in growth regulation and the in-
sulin-signaling pathway, has linkswith survival to old age (Suh et al.
2008), and is important in a variety of cancers (Klinakis et al. 2009;
Neuhausen et al. 2009; Sachdev et al. 2009). We suggest that IGF1R
and its DMR, therefore, represent interesting candidates for fu-
ture studies of parent-of-origin effects and epigenetic changes in
these conditions. However, we also note that no consistent parent-
of-origin effect on growth has been observed in patients carrying
mutations or copy-number changes of IGF1R (Abu-Amero et al.
1997; Walenkamp et al. 2006; Tatton-Brown et al. 2009).
Previous mapping of chromosome 15 rearrangements has de-
fined a minimal 687-kb region of 15q12-q13.1 (chr15:25,059,076–
25,747,771) as likely to contain an imprinted locus which, when
excess maternal copies are present, confers an increased risk of
psychosis in PWSpatients (Webb et al. 2008). This critical region lies
adjacent to a cluster of three gamma-aminobutyric acid receptor
genes that act as receptors for themajor inhibitoryneurotransmitter
of the brain. Several lines of evidence suggest these genes as candi-
date loci for neuropsychiatric disorders, including mouse knockout
and association studies linking them with autistic phenotypes
(Ma et al. 2005) and the observation that maternal, but not pa-
ternal, duplications of this region are seen in both autism and
schizophrenia (Cook et al. 1997;Webb et al. 2008).While previous
studies have yielded evidence suggesting that the GABAA gene
cluster in 15q12 is imprinted in humans (Meguro et al. 1997; Bittel
et al. 2005), there is also conflicting evidence suggesting that they
are not imprinted (Gabriel et al. 1998; Hogart et al. 2007). We
demonstrate that this 687-kb critical region contains a novel DMR
;150 kb distal to the 39 end of GABRG3, which we suggest,
therefore, likely represents the imprinted element responsible for
the increased risk of psychosis in PWS patients with matUPD15 or
maternal duplications of 15q12. We hypothesize that this DMR
represents an excellent candidate locus, genetic or epigenetic var-
iation of which might represent a more general risk factor for
psychosis. Given that maternal duplications of 15q11-q13 are also
one of the most frequent chromosomal abnormalities found in
autism (Schroer et al. 1998), and alterations of GABAA gene ex-
pression is frequent in autistic brains (Hogart et al. 2007), it is
tempting to speculate that this imprinted locusmay also have links
with autism and other psychiatric phenotypes. Of note, we ob-
served that this DMR distal to GABRG3 showed complete loss of
methylation in ;10% of apparently normal individuals, suggest-
ing that imprinting at this site is polymorphic. Similar poly-
morphic imprinting has previously been reported at some other
imprinted genes, such as IGF2R (Monk et al. 2006).We note that of
all of the DMRs that we detected on chr15, this region showed the
weakest parental difference in methylation (Fig. 1). While most of
the other DMRs we examined showed complete methylation of
maternal alleles and complete demethylation of paternal alleles,
the difference observed at GABRG3 was only partial, suggesting
that imprinting at this site is relatively weakly regulated. We sug-
gest that futurework to investigatemethylation levels at this site in
neuropsychiatric disorders might be fruitful.
We did not observe differential methylation at some sites
identified in previous studies. This included the promoter regions
of NDN (Lau et al. 2004) and MKRN3, although the latter was
reported to show only very slight differential methylation in most
somatic tissues (Jong et al. 1999). We also did not observe any
DMRs around RASGRF1, a gene that is known to be imprinted
and differentially methylated in mouse (Yoon et al. 2002). Based
on the sequence properties of a training set of imprinted and
nonimprinted genes, bioinformatic analyses has also predicted the
presence of up to 13 novel imprinted transcripts on chromosome
15 (Luedi et al. 2007). However, we did not observe DMRs at or
neighboring any of these 13 predicted imprinted genes.
It should be noted that the use of meDIP and array hybrid-
ization has some limitations. Firstly, its resolution is limited, being
only able to detect methylation changes at clusters of multiple
CpGs and potentially missing differences comprised of only a few
CpGs. More specifically, for the study of imprinting, some DMRs
associated with imprinted genes are only differentially methylated
in specific tissues, and other imprinted genes have been identified
that apparently lack nearby DMRs. Thus, the use of a single tissue
type for detecting imprinting will never be comprehensive. Fur-
thermore, while this technique is able to identify DNA elements
that carry parent-of-origin-specific epigenetic modifications, it
does not necessarily allow the definition of which genes have
imprinted expression, as in some cases these may lie hundreds of
kilobases away from the closest DMR. Despite these caveats, we
have identified many novel sites that show parent-of-origin epi-
genetic modifications that have been missed by other techniques,
indicating that analysis of uniparental tissues is a powerfulmethod
for detecting imprinting.
As the arrays we used also had coverage of chromosomes 12,
13, 14, and 16, we also investigated potential methylation differ-
ences at other loci outside of chromosome 15. Five loci on chro-
mosomes 12 and 14 that showed possible methylation differences
between individuals in our cohort were selected, but in each case,
bisulfite sequencing showed no significantmethylation difference
at these loci. Therefore, while our testing was limited, within the
sensitivity limits of our technique we did not find any evidence to
support the notion that uniparental disomy might cause methyl-
ation differences in trans.
In order to identify specific sequences thatmight play a role in
specifying DNA elements that are subject to imprinting, we per-
formed a preliminary investigation of two sequence-dependent
features of the DMRs that we identified: CpG periodicity and gua-
nine-quadruplex structure. DNMT3A is the enzyme responsible for
establishing methylation at imprinted sites in the maternal germ
line (Okano et al. 1999). Based on its crystal structure, which com-
prises a dimer with two active sites capable of methylating cytosine
residues spaced ;40 A˚ apart, it has been suggested that CpGs at
maternally imprinted loci show a periodicity of 8–9 bp (Ferguson-
Smith and Greally 2007; Jia et al. 2007). We tested whether the
spacing of CpGs within the maternally methylated DMRs we
identified on chromosome 15 exhibited similar periodicity, but did
not observe any discernable pattern at any of these 12 DMRs (Sup-
plementary Figs. 5, 6). Thus, our data do not support the hypothesis
that the regular spacing of CpGs, such as an 8–9-bp periodicity
suggested as the ideal substrate for de novo methylation by
DNMT3A, is a factor in determining imprinted loci.
Investigation of predicted secondary DNA structure resulting
from guanine-quadruplexes within 15q11-q13 showed that the
highest peak of potential G4 DNA occurs at a (CGGGGG)n tandem
repeat motif that is differentially methylated between maternal
and paternal alleles. This tandem repeat lies within the 1.15-kb
minimal region found in Angelman syndrome patients with im-
printing center mutations, deletion of which disrupts imprinting
within the 15q11-q13 region (Buiting et al. 1995; Ohta et al. 1999).
Tandem repeat motifs have also been identified within DMRs at
several other imprinted loci (Dindot et al. 2009), and in mouse,
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located within the Igf2r DMR are sufficient to establish imprinting
(Reinhart et al. 2002, 2006). Our observations raise the possibility
that the secondary structure of tandem repeats at DMRs is an im-
portant factor for establishing the correct pattern of imprinting
during gametogenesis.
Our analysis of DNA methylation patterns in patients with
UPD15 provides the first comprehensive map of imprinted loci
on chromosome 15. Unlike previous studies that have utilized
candidate gene or phenotype-driven approaches, we show that
methylation profiling in uniparental tissues represents an un-
biasedmethod to prospectively identify the specific DNA elements
that are epigenetically modified depending on their parental ori-
gin. We identify DMRs close to genes such as IGF1R and GABRG3,
both of which are known to be involved in several common hu-
man diseases, suggesting that imprinting is probably more com-
mon than is currently appreciated (Cheverud et al. 2008). Given
that uniparental disomy has been reported for almost every hu-
man chromosome (Kotzot and Utermann 2005), we predict that
further application of this technique will allow the comprehensive
assessment of parent-of-origin effects throughout most of the
human genome. Furthermore, the use of such imprinting maps to
incorporate parent-of-origin effects into disease association studies
may identify previously unrecognized epigenetic influences in
many human phenotypes (Kong et al. 2009).
Methods
Genomic DNA was extracted from peripheral blood samples from
(1) six unrelated patients with complete matUPD15 and a clin-
ical diagnosis of Prader-Willi syndrome, and (2) four unrelated pa-
tients with complete patUPD15 associated with Angelman syn-
drome. In each case, analysis of multiple microsatellite markers
distributed along chromosome 15 in the proband, and their par-
ents, suggested complete UPD for chromosome 15. Two of the pa-
tients with patUPD15 were isodisomic, while all of the other cases
used were heterodisomic.
Three cases with matUPD15 and three cases with patUPD15
weremethylation profiled bymicroarray hybridization, as follows.
Methylated DNA was immunoprecipitated using monoclonal an-
tibodies that recognize methylated cytosine (Weber et al. 2005).
Briefly, 15mg of DNAwas sonicated to generate fragments 200–800
bp in size (Branson 450D Sonifier), incubated with 10 mg of anti
5-methyl cytidine (Diagenode), immunoprecipitated using pro-
tein A sepharose beads (Life Technologies), and purified by phe-
nol:chloroform extraction. Immunoprecipitated and input DNA
from each case were labeled by random priming using Cy5 and
Cy3-conjugated random nonamers (TriLink BioTechnologies) and
hybridized to tiling oligonucleotide arrays.
We used arrays composed of 2.1 million 50–75-mer oligonu-
cleotides covering chromosomes 12, 13, 14, 15, and 16 at amedian
probe density of 1 per 100 bp (Roche Nimblegen). Of these,
612,834 probes cover the 82.1-Mb sequenced portion of chromo-
some 15. DNA labeling, array hybridizations, and washes were
performed according to manufacturer’s recommendations, and
slides were scanned using a G2565 scanner at 5 mm resolution
(Agilent Technologies). Array images were analyzed using Nim-
bleScan v2.5 software (Roche NimbleGen) with default parameters
incorporating spatial correction, and the resulting files of probe
log2 ratios were used for subsequent analysis. All experiments were
performed in duplicate.
We developed a custom analysis pipeline to detect regions of
differential methylation between individuals with matUPD15 and
patUPD15. To avoid systematic bias when comparing different
arrays, for example, resulting from differences in the antibody
enrichment or labeling efficiency between different DNA samples,
we applied quantile normalization (Bolstad et al. 2003; Supple-
mentary Fig. 1). Subsequently, a sliding window analysis was
implemented to identify low-confidence data points (outliers)
based on the deviation in the log2 ratio of a probe from its im-
mediate neighbors. This approach utilizes the fact as the mean
probe spacing (;100 bp) is considerably less than the mean size of
DNA fragments hybridized to the array (;500 bp), closely spaced
probes are expected to show correlated values. Outlier probes were
identified using a sliding window that identified all clusters of five
consecutive probes, which spanned a physical distance of 1 kb or
less. For each group of probes, if the difference in log2 values be-
tween the central probe and the median value of the probe cluster
was larger than the interquartile range of log2 values on chr 15
(0.97), it was considered an outlier, and its value was replaced with
the median log2 ratio of the remaining four probes in the group.
This procedure resulted in the replacement of an average of 3.2% of
probes per array. Overall, these normalization and filtering steps
resulted in significant noise reduction and improvements to data
quality, with the mean correlation between log2 ratios in replicate
hybridizations for the six individuals tested increasing from 0.83
in the raw data to 0.93 after quantile normalization and outlier
replacement. We then applied a linear smoothing function
(Pelizzola et al. 2008) with a window size of 1 kb, although this was
only used for visualization purposes, not for differential meth-
ylation analysis. An example of the results of outlier replacement
and weighted smoothing are shown in Supplementary Figure 2.
Prior to further analyses, probes were prefiltered for variance,
and those with a standard deviation <0.2 were removed (n =
76,485, or 12.5% of the probes on chr 15). Finally, a modified
t-statistic as implemented in the LIMMA software package (Smyth
2004) was calculated to determine the significance value of dif-
ferential methylation for each remaining probe between
matUPD15 and patUPD15 samples. Since we were analyzing both
biological and technical replicates, a mixed model analysis was
used (Smyth et al. 2005). False discovery rate (FDR) (Benjamini and
Hochberg 1995) multiple testing correction was applied. Putative
regions of differential methylation were identified by analyzing all
clusters of five consecutive probes with a span of <1 kb. Putative
regions of differential methylation were identified based on the
presence of clusters of multiple independent probes that exceeded
a relatively low-stringency statistical threshold, suited for the dis-
covery of novel DMRs. Clusters were scored as differentially meth-
ylated if the central probe had an FDR-adjusted P < 0.1 and at least
two of the four neighboring probes had an unadjusted P < 0.05.
Overlapping intervals identified by this approach were merged to
form a nonredundant set. All statistical analyses were performed
using software from the Bioconductor project (Gentleman et al.
2004).
For validation of putative DMRs, we designed primers to
amplify bisulfite converted DNA usingMethyl Primer Express v1.0
(Life Technologies). Primers were designed for 22 of the 29 sites
identified by array analysis, while for the remaining seven regions
it was not possible to design successful assays, due either to the
presence of common repeat elements and/or the difficulties of
designing specific primers for reduced-complexity bisulfite-treated
DNA (Supplementary Table 1). A total of 2 mg of genomic DNA
from patients withmatUPD15, patUPD15, and control individuals
was bisulfite converted and purified using Epitect Bisulfite Kits
(Qiagen). Bisulfite-treated DNA was amplified using JumpStart
REDTaq DNA Polymerase (Sigma), unincorporated primers and
nucleotides were removed by incubation with Exonuclease I and
Shrimp Alkaline Phosphatase (New England BioLabs), and the
products were subjected to Sanger sequencing. In addition to bi-
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DNAs derived from peripheral blood. A minimum of four controls
were tested at each locus.
To allow separate bisulfite sequencing of the maternal and
paternal alleles in a normal control sample with biparental in-
heritance of chromosome 15, a HapMap individual (NA12753)
heterozygous for informative polymorphisms within each PCR
amplicon was identified from publicly available SNP genotype
data (http://hapmap.ncbi.nlm.nih.gov/). After amplification of
bisulfite converted DNA, PCR products were cloned by TOPO TA
cloning (Life Technologies) and transformants grown on agar
plates supplemented with X-Gal. Individual colonies containing
an insert were reamplified and sequenced, maternal and paternal
alleles separated based on their SNP genotype, and the methyla-
tion state of each CpG dinucleotide visualized using CpGViewer
(http://dna.leeds.ac.uk/cpgviewer/).
Allele-specific expression studies were performed by Sanger
sequencing of both DNA and cDNA in individuals carrying tran-
scribed polymorphisms of IGF1R and OCA2. For IGF1R, we used
RNA extracted from placenta and cord blood from newborns, and
for OCA2, RNA was obtained from cultured melanocytes. We were
unable to examine GABRG3 due to its tissue-limited expression
pattern.
Putative sites of guanine-quadruplex DNA were identified
using QRGS Mapper (http://bioinformatics.ramapo.edu/QGRS/
analyze.php), which identifies and assigns a score to DNA motifs
based on their sequence. To assess the relative potential of genomic
regions to adopt G-quadruplex structures on a local level, QRGS
Mapper was run using default parameters, and the total summed
scores of all overlapping sites for each 100-bp window within
15q11-q13 were calculated.
We assessed the periodicity of CpG sites within validated
DMRs on chromosome 15. CpG periodicity was measured for each
DMR that overlapped an updated set of CpG islands (Bock et al.
2007) and the results assessed both individually and as a single
combined group to give improved power using a larger dataset. In
each case, periodicity was analyzed by compiling an all-by-all
matrix that measured the distance of each CpG from every other
CpG within that CpG island, and the frequency with which each
inter-CpG distance occurred was plotted graphically.
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